rare diseases

South Korea's Celltrion Inc. announced on Monday it received a new drug approval for an autoimmune disease treatment Remsima SC (active ingredient i...

South Korea's Celltrion Healthcare Co. announced on Wednesday its autoimmune disease treatment Remsima (ingredient: infliximab) has won a bid for ho...

South Korean vaccine developer Quratis Inc. on Wednesday announced its signing of a term sheet on the direction and major transaction terms of coope...

South Korean medical diagnostic company NGeneBio Co. announced on Thursday that it has completed the US patent application for its technology relate...

South Korea's VaxCell Biotherapeutics Co. on Tuesday said its treatment for advanced liver cancer under development stopped or greatly reduced the g...

Samsung Bioepis Co., a biopharmaceutical research and development unit under South Korea's Samsung Group, announced on Monday that it signed a partn...

South Korea's Yungjin Pharm has secured Fast Track designation from the US Food and Drug Administration (FDA) for its new drug candidate KL1333, des...

South Korea’s Boryung Corp. on Tuesday said it received approval from the Ministry of Food and Drug Safety for its new compound diabetes drug ...

South Korean pharmaceutical company Handok Inc. on Wednesday said it signed a deal with Dutch immunology specialist Argenx to sell the latter's Vyvg...

South Korea is far more dependent than Japan on neodymium permanent magnets from China at 88%, while the rate for Japan, a land devoid of rare earth...

South Korea's Daewoong Pharmaceutical announced on Tuesday that it has launched the GERD treatment drug "Fexuclue" (active ingredient: Fexuprazan) i...

South Korean pharmaceutical company Kwangdong Pharmaceutical announced on Monday that it signed an agreement for securing exclusive sales and distri...

South Korea’s SK Biopharmaceuticals Co. is aiming to triple its enterprise value to $15 billion by 2026 with the goal of rising to the top run...

South Korea’s GI Innovation Inc. aims to complete licensing of its allergic diseases treatment candidate to a Japanese drug company by year's ...

South Korean biopharmaceutical company Celltrion Inc. on Friday said it applied for approval from the US Food and Drug Administration (FDA) for CT-P...

Asan Medical Center announced plans on Thursday to establish a 65-bed gastrointestinal specialized hospital in Dubai Healthcare City in Dubai, UAE, ...

Busan Equity Partners (BEP), a South Korean private equity firm, is partnering with Philippine mineral development company PGMPI to develop overseas...

An early-stage startup by young entrepreneurs who developed a digital diagnostic tool for brain disease and an AI-powered business optimization prog...

South Korea's Samsung Bioepis has received approval in Europe to sell a biosimilar of Soliris, a drug for the treatment of adult and children patien...

South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has obtained product approval from the US Food and Drug Adminis...

The number of young workers in South Korea fell for a sixth straight month in April to its lowest point in more than two years, deepening concerns t...

South Korea's Daewoong Pharmaceutical announced on Friday that it has signed a technology export contract for the clinical development and commercia...

South Korean biopharmaceutical company Celltrion Healthcare Co. on Thursday said it ranked in the top 10 out of 400 companies last year on the Turki...

South Korean drugmaker Daewoong Pharmaceutical Co. said on Tuesday that it has signed a cooperation agreement with Sygnature Discovery, a British ne...

South Korea's steelmaker POSCO and the government-run Korea Mine Rehabilitation and Mineral Resources Corp. (KOMIR) on Friday announced the first pi...

South Korea's pharmaceutical company HLB Therapeutics Co. announced on Thursday that it has started patient administration of "RGN-259," a treatment...

Koo Kwang-mo, chairman of South Korea’s fourth-largest conglomerate LG, has been sued over the distribution of inherited wealth, including a s...

Samsung Bioepis Co., a South Korean biosimilar firm, announced on Sunday that it has recently launched a new biosimilar drug called SB11 for the tre...

South Korea's GC Biopharma Corp. announced on Tuesday that it had entered into an agreement to transfer assets with Catalyst Biosciences, a US-based...

South Korea's Daesang Wellife Corp. has inked a 2 billion won ($1.5 million) investment contract with local healthcare data science company RexSoft ...